Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
MEDI-1814 by AstraZeneca for Alzheimer's Disease: Likelihood of Approval
MEDI-1814 is under clinical development by AstraZeneca and currently in Phase I for Alzheimer's Disease. According to GlobalData, Phase I...